Canterbury University is part of the MARS program. This multi-institute group is developing world leading spectral X-Ray imaging technology for medical and other applications. Our partner MARS Bioimaging Ltd is commercialising this technology.
In particular, the University of Canterbury is a member of CERN's Medipix3, Medipix4, and CMS collaborations.
Each of these activities have more extensive webpages that can be found under the resources section of this page.